Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Higgins

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
British Journal of Pharmacology|July 1, 1979
Protection against experimental myocardial ischaemia by L-4-hydroxy-phenylglycine, a new agent which alters myocardial metabolic balance in favour of carbohydrate utilisation [proceedings]K J Blackburn, R A Burges, D G Gardiner, et al.
European Journal of Pharmacology|May 14, 1992
Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogsM Gwilt, K J Blackburn, R A Burges, et al.
Journal of Cardiovascular Pharmacology|March 1, 1991
Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agentM Gwilt, H W Dalrymple, R A Burges, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cellsM Gwilt, J E Arrowsmith, K J Blackburn, et al.
Respiratory Medicine|May 1, 1990
Comparative assessment of enprofylline and theophylline for chronic obstructive airways disease in the elderlyJ D Arnold, R J Courtenay-Evans, R Whitfield, et al.
Journal of Cardiovascular Pharmacology|May 1, 1994
Inhibition of long-chain acylcarnitine accumulation during coronary artery occlusion does not alter infarct size in dogsW M Vogel, L R Bush, G C Cavallo, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptorsR A Burges, D G Gardiner, M Gwilt, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
British Journal of Pharmacology|July 1, 1979
Protection against experimental myocardial ischaemia by L-4-hydroxy-phenylglycine, a new agent which alters myocardial metabolic balance in favour of carbohydrate utilisation [proceedings]K J Blackburn, R A Burges, D G Gardiner, et al.
European Journal of Pharmacology|May 14, 1992
Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogsM Gwilt, K J Blackburn, R A Burges, et al.
Journal of Cardiovascular Pharmacology|March 1, 1991
Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agentM Gwilt, H W Dalrymple, R A Burges, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cellsM Gwilt, J E Arrowsmith, K J Blackburn, et al.
Respiratory Medicine|May 1, 1990
Comparative assessment of enprofylline and theophylline for chronic obstructive airways disease in the elderlyJ D Arnold, R J Courtenay-Evans, R Whitfield, et al.
Journal of Cardiovascular Pharmacology|May 1, 1994
Inhibition of long-chain acylcarnitine accumulation during coronary artery occlusion does not alter infarct size in dogsW M Vogel, L R Bush, G C Cavallo, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptorsR A Burges, D G Gardiner, M Gwilt, et al.
Pageof 9